[HTML][HTML] Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
C Schneidawind, V Hagmaier, C Faul, L Kanz… - Annals of …, 2018 - Springer
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia.
C Schneidawind, V Hagmaier, C Faul, L Kanz… - Annals of …, 2018 - europepmc.org
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia.
C Schneidawind, V Hagmaier, C Faul… - Annals of …, 2018 - search.ebscohost.com
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
[引用][C] Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
C Schneidawind, V Hagmaier… - Annals of …, 2018 - tobias-lib.ub.uni-tuebingen.de
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival
in relapsed acute leukemia Second allogeneic hematopoietic cell transplantation enables …
in relapsed acute leukemia Second allogeneic hematopoietic cell transplantation enables …
[引用][C] Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
C Schneidawind, V Hagmaier, C Faul… - Annals of …, 2018 - ub01.uni-tuebingen.de
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival
in relapsed acute leukemia Second allogeneic hematopoietic cell transplantation enables …
in relapsed acute leukemia Second allogeneic hematopoietic cell transplantation enables …
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
C Schneidawind, V Hagmaier, C Faul… - Annals of …, 2018 - search.proquest.com
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
C Schneidawind, V Hagmaier, C Faul… - Annals of …, 2018 - pubmed.ncbi.nlm.nih.gov
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for high-risk
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
myeloid and lymphoid leukemias. Relapse after allogeneic HCT is associated with a dismal …
[引用][C] Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
C Schneidawind, V Hagmaier, C Faul, L Kanz… - Annals of …, 2018 - cir.nii.ac.jp
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival
in relapsed acute leukemia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
in relapsed acute leukemia | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …